DAVID R. STRAYER, M.D.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

AIM ImmunoTech Inc.

Filing Date Source Excerpt
2019-04-24 Dr. Strayer is our Chief Scientific Officer and Chief Medical Director who has ownership of 94,304 shares of Common Stock and beneficially owns 447,931 shares issuable upon exercise of options.

Data sourced from SEC filings. Last updated: 2025-10-11